ROLE OF MEMORY T CELL DYNAMICS IN SIV INFECTION

记忆 T 细胞动力学在 SIV 感染中的作用

基本信息

  • 批准号:
    8357743
  • 负责人:
  • 金额:
    $ 19.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Our work has provided compelling evidence that the onset of immune deficiency in pathogenic SIVmac239 infection of rhesus macaques (RM) is intimately linked with patterns of CD4+ memory T cell dynamics, and reflects a complex interplay of direct viral cytopathogenicity, and the indirect effects of persistent immune activation on CD4+ memory T cell proliferation, differentiation and survival. Our data have strongly implicated a decline in effector site, CD4+ effector memory (TEM) populations below a crucial threshold as a major proximate mechanism of overt immunodeficiency, but significantly, have also demonstrated that in CCR5-tropic SIV infection, even massive viral-mediated destruction of CD4+ TEM is rarely, if ever, sufficient for functional failure of this population. Instead, our data indicate that this failure is determined in large part by the ability of CD4+ central memory T cells (TCM) to produce new TEM, which in turn depends on the maintenance of the CD4+ TCM population itself. In chronic SIV infection, we found that a slow decline of the number and often, proliferative activity of CD4+ TCM underlies CD4+ TEM population failure, and "sets the clock" for the onset of overt disease. Recent work has focused on the mechanisms responsible for CD4+ TCM homeostatic failure, in particular the role of IL-7 and IL-15 in maintaining CD4+ TCM homeostasis and the relative contribution of recruitment of new TCM from the na¿ve compartment vs. regeneration of pre-existent TCM in the maintenance of the CD4+ TCM compartment during progressive SIV infection. By mAb-mediated depletion of CD4+ T cell in thymectomized monkeys, we have created "CD4 naiveless" RM after memory cells regenerate in the absence of a thymus. Importantly, the lack of a na¿ve CD4+ T cell compartment has little measureable effect on the maintenance of CD4+ memory T cells after SIV infection, suggesting that maintenance of this population depends predominantly on the regeneration of pre-existent memory cells as opposed to na¿ve cell recruitment. Other work in this project has looked at B cell dynamics in SIV infection and mechanisms by which CD8+ T cells affect SIV replications and pathogenesis.
这个子项目是利用这些资源的众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Louis J. Picker其他文献

760. Overcoming Rhesus Macaque Endogenous Restriction Factors during HIV-1 Vector Transduction
  • DOI:
    10.1016/j.ymthe.2006.08.844
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Christina H. Swan;Udayan Chatterji;Philippe Gallay;Louis J. Picker;Bruce E. Torbett
  • 通讯作者:
    Bruce E. Torbett
Pulmonary Artery-Bronchial Fistula Complicating Chronic Lymphocytic Leukemia
  • DOI:
    10.1378/chest.86.1.134
  • 发表时间:
    1984-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    James K. Stoller;Louis J. Picker;Scott T. Weiss;Robert L. Thurer;Earl J. Kasdon
  • 通讯作者:
    Earl J. Kasdon
Antibodies advance the search for a cure
抗体推动了对治愈方法的探索
  • DOI:
    10.1038/nature12703
  • 发表时间:
    2013-10-30
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Louis J. Picker;Steven G. Deeks
  • 通讯作者:
    Steven G. Deeks
Seeking ultimate victory
追求最终的胜利
  • DOI:
    10.1038/nature14194
  • 发表时间:
    2015-01-07
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Louis J. Picker;Jeffrey D. Lifson
  • 通讯作者:
    Jeffrey D. Lifson
Programming cytomegalovirus as an HIV vaccine
将巨细胞病毒编程为一种 HIV 疫苗
  • DOI:
    10.1016/j.it.2023.02.001
  • 发表时间:
    2023-04-01
  • 期刊:
  • 影响因子:
    13.900
  • 作者:
    Louis J. Picker;Jeffrey D. Lifson;Michael Gale;Scott G. Hansen;Klaus Früh
  • 通讯作者:
    Klaus Früh

Louis J. Picker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Louis J. Picker', 18)}}的其他基金

Project 1: Systemic analysis of the origin and tissue effects of the 68-1 RhCMV/SIV vaccine efficacy-predictive whole blood transcriptomic signature
项目1:68-1 RhCMV/SIV疫苗功效预测全血转录组特征的起源和组织效应的系统分析
  • 批准号:
    10723639
  • 财政年份:
    2023
  • 资助金额:
    $ 19.49万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10709003
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
RhCMV/SIV 疫苗诱导复制抑制功效的免疫学和病毒学基础
  • 批准号:
    10619297
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
项目 3:确定 RhCMV/SIV 疫苗介导的 SIV 复制抑制功效所需的最小 MHC-E 限制性 SIV 表位靶向
  • 批准号:
    10709020
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10619298
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
RhCMV/SIV 疫苗诱导复制抑制功效的免疫学和病毒学基础
  • 批准号:
    10709002
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
项目 3:确定 RhCMV/SIV 疫苗介导的 SIV 复制抑制功效所需的最小 MHC-E 限制性 SIV 表位靶向
  • 批准号:
    10619304
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
用于 HIV/AIDS 疫苗的免疫原性和功效优化的 CMV 载体的开发
  • 批准号:
    9883700
  • 财政年份:
    2017
  • 资助金额:
    $ 19.49万
  • 项目类别:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
安全性增强的 RhCMV/SIV 载体的开发和体内表征
  • 批准号:
    8227957
  • 财政年份:
    2011
  • 资助金额:
    $ 19.49万
  • 项目类别:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
安全性增强的 RhCMV/SIV 载体的开发和体内表征
  • 批准号:
    8416334
  • 财政年份:
    2011
  • 资助金额:
    $ 19.49万
  • 项目类别:

相似海外基金

Characterizing RNA regulation in B lymphocytes
B 淋巴细胞中 RNA 调控的特征
  • 批准号:
    502601
  • 财政年份:
    2024
  • 资助金额:
    $ 19.49万
  • 项目类别:
Characterization of Streptococcus suis interactions with B lymphocytes
猪链球菌与 B 淋巴细胞相互作用的表征
  • 批准号:
    573206-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
    University Undergraduate Student Research Awards
B Lymphocytes in Autoimmune Disease
自身免疫性疾病中的 B 淋巴细胞
  • 批准号:
    10370125
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
Altered B lymphocytes Due to Tungstate Exposure
钨酸盐暴露导致 B 淋巴细胞发生改变
  • 批准号:
    RGPIN-2020-05899
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
    Discovery Grants Program - Individual
The regulation of signaling and cytoskeletal rearrangements in B-lymphocytes
B 淋巴细胞信号传导和细胞骨架重排的调节
  • 批准号:
    RGPIN-2019-04911
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
    Discovery Grants Program - Individual
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
  • 批准号:
    10543825
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
  • 批准号:
    10339541
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
Exploring RNA helicase DDX the role of the1 at the crossroad of DNA repair processes in B lymphocytes
探索 RNA 解旋酶 DDX 在 B 淋巴细胞 DNA 修复过程十字路口的作用
  • 批准号:
    BB/X511560/1
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
    Training Grant
Role and regulation of extracellular vesicles generated in response to stimulation of CD24 on B lymphocytes
B 淋巴细胞上 CD24 刺激产生的细胞外囊泡的作用和调节
  • 批准号:
    RGPIN-2022-03800
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
    Discovery Grants Program - Individual
B Lymphocytes in Autoimmune Disease
自身免疫性疾病中的 B 淋巴细胞
  • 批准号:
    10640819
  • 财政年份:
    2022
  • 资助金额:
    $ 19.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了